IHI: Europe’s Research And Innovation Project Is A Watchtower For Medtechs

A New Era In Cross-Industry Funded Health Care R&I Projects Is Getting Underway In Europe

April will see the first call for proposals under the Innovative Health Initiative, a patient-centric, demand-led project that is about to come to life for technology innovators after 30 months of negotiations and preparations by European health care industry associations and the European Commission.

European Union stars symbol against violet glass building wall - Image
• Source: Alamy

Europe’s ground-breaking Innovative Health Initiative (IHI), a new Horizon Europe public-private partnership, is finally on the cusp of being fully operational. The joint EU and European life science industry associations initiative is aimed at finding innovative solutions to unmet health care needs.

The launch schedule suffered a few months’ slippage after the EU’s adoption of its general regulation on partnerships was delayed until 30 November 2021.

The IHI was officially inaugurated in January, having been further delayed ̶ health care being a complex theme – due to the requirement for a Science and Innovation Panel (SIP)....

More from Innovation

AI In Health Delivery: Patients Most Confident When HCPs Are In Charge

 
• By 

Annual survey of patients and professionals shows how attitudes to health system transformation are evolving and what stakeholders are demanding as acceptance of AI tools accelerates.

Medtech Innovators Court London-Based Investors At BioWales 2025

 
• By 

BioWales in London 2025 showcased the efforts healthtech innovators are making to meet investors on their own turf, illustrating changing attitudes and evolving needs.

UK Bets On Regulatory Innovation As Competitive Advantage In Synthetic Biology

 
• By 

The UK government has prioritized synthetic biology and created a "concierge service" for biotechs just as the US cuts science funding.

Leaders At The Frontier: Conversations From SynBioBeta 2025

 
• By 

Mini-profiles of five synthetic biology companies and their leaders from SynBioBeta 2025 reveal how AI integration, data-driven platforms and interdisciplinary teams are revolutionizing drug discovery and manufacturing.

More from In Vivo